BIOMARKER:

TOP2A overexpression

Entrez ID:

TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	rubitecan Sensitive: D – Preclinical	rubitecan Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	teniposide Sensitive: D – Preclinical	teniposide Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	etoposide oral Sensitive: D – Preclinical	etoposide oral Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	pirarubicin Sensitive: D – Preclinical	pirarubicin Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	mitoxantrone Sensitive: D – Preclinical	mitoxantrone Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	idarubicin hydrochloride Sensitive: D – Preclinical	idarubicin hydrochloride Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	SA033 Sensitive: D – Preclinical	SA033 Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	daunorubicin Sensitive: D – Preclinical	daunorubicin Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	TOP2A overexpression TOP2A overexpression	Adrenal Cortex Carcinoma Adrenal Cortex Carcinoma	aclarubicin Sensitive: D – Preclinical	aclarubicin Sensitive: D – Preclinical
TOP2A overexpression TOP2A overexpression	Multiple Myeloma Multiple Myeloma	TOP2A overexpression TOP2A overexpression	Multiple Myeloma Multiple Myeloma	carfilzomib Resistant: D – Preclinical	carfilzomib Resistant: D – Preclinical